Sunshine Lake Pharma Co., Ltd. Class H 6887
HKEX · Hong Kong SAR China · Health Technology
HKD 43.00-1.00 (-2.27%)
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Sunshine Lake Pharma (SEHK:6887) is back on trader screens after a recent price move that left the stock up around 3% on the day and modestly higher over the past month. Short term momentum in Sunshine Lake Pharma has picked up, with 1 day, 7 day and 30 day share price returns of 2.93%, 4.09% and 4.35% respectively. However, the share price return year to date is still down 8.69%, and the 1 year total shareholder return has declined 17.29%, even after a very strong 3 year and 5 year total...
Langlara is manufactured by Sunshine Lake Pharma, part of the HEC Group and commercialised in the US via Lanexa Biologics.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.